Add Formweb to your mobile device
Brand name products with an equivalent generic may not be available to order at Henry Ford Health. For questions, contact inpatient pharmacy.
Search results for:
epoetin alfa
epoetin alfa
| Drug Name | Form | Strength | Ambulatory Use Only | Ambulatory Restrictions | Inpatient Restrictions | Non-Formulary |
|---|---|---|---|---|---|---|
| Retacrit | SOLUTION, INJECTABLE | epbx 2000 units/mL PF; 4000 units/mL PF; 10,000 units/mL PF; 40,000 units/mL PF | ||||
| Epogen | SOLUTION, INJECTABLE | 10,000 units/mL preservative-free; 2000 units/mL preservative-free; 4000 units/mL preservative- | ||||
| Procrit | SOLUTION, INJECTABLE | 40,000 units/mL preservative-free; 4000 units/mL preservative-free; 20000 units/mL |
VIEW MORE biologicals, erythropoiesis-stimulating agents
| Generic Name | Brand Name | |
| Biosimilar (HFH preferred) | epoetin alfa-epbx | Retacrit |
| Originator product | epoetin alfa | Epogen and Procrit |
Last updated: Jan. 7, 2026
- Biosimilar Use of Biosimilars at Henry Ford Health System
- Black Box Warning Risk of mortality, tumor progression, cardiac events
- Policy Use of Biosimilars at Henry Ford Health System